Peter A. Cohen
- Immunology top 0.5%
- Immunotherapy and Immune Responses 56
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 20
- Immune Response and Inflammation 12
- Immune cells in cancer 9
- Oncology top 1%
- CAR-T cell therapy research 23
- Cancer Immunotherapy and Biomarkers 20
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 7
- Cancer Research top 5%
- Biotechnology top 5%
- Co-authors
- James H. FinkeJennifer S. KoGary K. KoskiBrian I. RiniSuyu ShuJoanna IrelandPatricia RaymanBrian J. Czerniecki
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- The Journal of Immunology (13 papers)Critical Reviews in Immunology (6 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesCanadaMalaysia
In The Last Decade
Peter A. Cohen
83 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Immunology 3.5k
- Oncology 2.0k
- Molecular Biology 1.6k
- Cancer Research 321
- Biotechnology 133
Countries citing papers authored by Peter A. Cohen
This map shows the geographic impact of Peter A. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Cohen more than expected).
Fields of papers citing papers by Peter A. Cohen
This network shows the impact of papers produced by Peter A. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Cohen. The network helps show where Peter A. Cohen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter A. Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 15 | |
| 2 | 2016 | 46 | |
| 3 | 2014 | 42 | |
| 4 | 2013 | 17 | |
| 5 | 2012 | 27 | |
| 6 | 2011 | 1 | |
| 7 | 2010 | 223 | |
| 8 | 2010 | 18 | |
| 9 | Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patientsbreakdown → | 2009 | 690 |
| 10 | 2008 | 111 | |
| 11 | 2008 | 4 | |
| 12 | 2008 | 48 | |
| 13 | 2006 | 20 | |
| 14 | 2004 | 101 | |
| 15 | 2004 | 24 | |
| 16 | 2001 | 61 | |
| 17 | 2000 | 354 | |
| 18 | 2000 | 27 | |
| 19 | 2000 | 39 | |
| 20 | 1994 | 93 |
About Peter A. Cohen
Peter A. Cohen is a scholar working on Immunology, Oncology and Leadership and Management, having authored 85 papers that have together received 5.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (56 papers), CAR-T cell therapy research (23 papers), Immune Cell Function and Interaction (21 papers), Cancer Immunotherapy and Biomarkers (20 papers), T-cell and B-cell Immunology (20 papers), Immune Response and Inflammation (12 papers), Immune cells in cancer (9 papers) and Glycosylation and Glycoproteins Research (7 papers). The work is most often cited by research in Immunology (3.5k citations), Oncology (2.0k citations) and Molecular Biology (1.6k citations). Peter A. Cohen has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include James H. Finke, Jennifer S. Ko, Gary K. Koski, Brian I. Rini, Suyu Shu, Joanna Ireland, Patricia Rayman, Brian J. Czerniecki, Shuwen Xu and Sandra Gendler. Their work appears in journals such as The Journal of Immunology, Critical Reviews in Immunology, Clinical Cancer Research, Blood and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.